Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

February 25, 2021

Outcomes of adults with repaired tetralogy of Fallot from the national Scottish Cohort.

Cardiology in the Young
Richard J DobsonMark H D Danton
February 25, 2021
Comment / Editorial
Open Access

Commentary: Concomitant surgical ablation of atrial fibrillation significantly improves late survival.

The Journal of Thoracic and Cardiovascular Surgery
Leonid Sternik
February 25, 2021
Open Access

Cheap and simple, could it get even cooler? Mild hypothermia and COVID-19.

Journal of Critical Care
Raul Dos Reis Ururahy, Marcelo Park
February 25, 2021

Next frontier in management of atrial fibrillation.

Heart
Nicole LowresBen Freedman
February 25, 2021
Open Access

Economic value of insertable cardiac monitors in unexplained syncope in the United States.

Open Heart
Brad S SuttonMatthew R Reynolds
February 25, 2021

Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain.

European Heart Journal Cardiovascular Imaging
Francesco AnconaEustachio Agricola
February 25, 2021
Open Access

QTc-interval prolongation and increased risk of sudden cardiac death associated with hydroxychloroquine.

European Journal of Preventive Cardiology
Fariba AhmadizarBruno H Stricker
February 25, 2021

Life Course Socioeconomic Status and Risk of Hospitalization for Heart Failure or Atrial Fibrillation in The Moli-Sani Study Cohort.

American Journal of Epidemiology
Marialaura BonaccioOn Behalf Of The Moli-Sani Study Investigators
February 25, 2021

Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management.

European Journal of Preventive Cardiology
Giuseppe BorianiRiccardo Asteggiano
February 25, 2021

What do we really know about anticoagulation in patients with cancer and atrial fibrillation?

European Journal of Preventive Cardiology
Diego PenelaRiccardo Cappato
February 25, 2021

Integrated care for atrial fibrillation: the heart of the matter.

European Journal of Preventive Cardiology
Celine GallagherDennis H Lau
February 25, 2021
Open Access

Association of atrial fibrillation and left atrial volume index with mortality in patients with COVID-19 pneumonia.

European Journal of Preventive Cardiology
Antonello D'AndreaEduardo Bossone
February 25, 2021

Predicting the risk of atrial fibrillation: is the machine learning the answer?

European Journal of Preventive Cardiology
Geza Halasz
February 25, 2021

Utility of risk prediction models to detect atrial fibrillation in screened participants.

European Journal of Preventive Cardiology
Michiel H F PoorthuisRichard Bulbulia
February 25, 2021
Open Access

Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement: the complexity of the elderly.

European Journal of Preventive Cardiology
Leonardo BencivengaGiuseppe Rengo

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2021 Meta ULC. All rights reserved
/feed-previews/atrial-fibrillation/fabf0ae5-d226-462e-a582-cafb51ddf796